The unwanted response to cardiac surgery: Time for a reappraisal?

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 1, 2003, Pages 32-35

  Royston, David ^a   Kovesi, Tomas ^a   Marczin, Nandi ^a,b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENT COMPONENT C4; CYTOKINE; DIURETIC AGENT; INOTROPIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; BODY TEMPERATURE; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CORRELATION ANALYSIS; DISEASE MARKER; DRUG MECHANISM; EDITORIAL; EPIDEMIOLOGICAL DATA; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; MEDIATOR RELEASE; META ANALYSIS; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0037245386     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.6     Document Type: Editorial

References (21)

1. Royston D. The evolution of coagulation and inflammation. In: Spiess BD, editor. The relationship between coagulation, inflammation and the endothelium-A pyramid towards outcome. A Society of Cardiovascular Anesthesiologists monograph. Philadelphia: Lippincott Williams & Wilkins; 2000. p 1-30.
2. Muckart DJ, Bhagwanjee S. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med. 1997;25:1789-95.
3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-57.
4. Schmartz D, Tabardel Y, Preiser J-C, Barvais L, d'Hollander A, Duchateau J, et al. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg. 2003;125:184-90.
5. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816-23.
6. Christenson JT, Aeberhard JM, Badel P, Pepcak F, Maurice J, Simonet F, et al. Adult respiratory distress syndrome after cardiac surgery. Cardiovasc Surg 1996;4:15-21.
7. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343-8.
8. Tsiotos GG, Mullany CJ, Zietlow Svan Heerden JA. Abdominal complications following cardiac surgery. Am J Surg. 1994;167:553-7.
9. Stahle E, Tammelin A, Bergstrom R, Hambreus A, Nystrom SO, Hansson HE. Sternal wound complications: incidence, microbiology and risk factors. Eur J Cardiothorac Surg. 1997;11:1146-53.
10. Hernandez F, Cohn WE, Baribeau YR, Tryzelaar JF, Charlesworth DC. Clough RA, et al. In-hospital outcomes of off-pump versus on-pump coronary artery bypass procedures: a multicenter experience. Ann Thorac Surg. 2001;72(5):1528-34.
11. Chandler WL, Fitch JC, Wall MH, Verrier ED, Cochran RP, Soltow LO, et al. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost. 1995;74:1293-7.
12. Paugam C, Chollet-Martin S, Dehoux M, Chatel D, Brient N, Desmonts JM, et al. Neutrophil expression of CD11b/CD18 and IL-8 secretion during normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:575-9.
13. Antonelli M. Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? J Chemother. 1999;11:536-40.
14. Lehmann AK, Halstensen A, Sornes S, Rokke O, Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immunol. 1995;63:2109-12.
15. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170-3.
16. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998;351:950-3.
17. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-8.
18. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999;354:1940-7.
19. Royston D. Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass. J Cardiovasc Pharmacol. 1996;27(Suppl 1):S42-9.
20. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:745-54.
21. Wang JH, Redmond HP, Watson RW, Duggan S, McCarthy J, Barry M, et al. Mechanisms involved in the induction of human endothelial cell necrosis. Cell Immunol. 1996;168:91-9.